Antibody-Drug Conjugates in Urothelial Carcinomas
Michal Sarfaty, Jonathan E. Rosenberg
Topics & Concepts
MedicineAntibody-drug conjugateBrentuximab vedotinBladder cancerMetastatic Urothelial CarcinomaMalignancyDurvalumabMonoclonal antibodyOncologyDrugImmunotherapyAntibodyCancer researchCancerInternal medicinePharmacologyImmunologyPembrolizumabUrothelial carcinomaTumor cellsCD30Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesEsophageal Cancer Research and Treatment